# Pfizer Inc. – FDA 483, Sep 22, 2017

Source: https://www.keypedia.com/records/483/pfizer-inc/8ee3fdca-bb25-4c24-a736-b48d75f0f082

> FDA 483 for Pfizer Inc. on September 22, 2017. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Pfizer Inc.
- Inspection Date: 2017-09-22
- Product Type: drugs
- Office Name: Division of Northeast Imports 
- Summary: Pfizer Inc. Groton Laboratories, a GLP Testing Facility in Groton, CT, received a Form 483 with two observations. The inspection revealed issues with the retention of raw data from nonclinical laboratory studies and inadequate record-keeping for equipment maintenance and quality control data. These findings indicate deficiencies in data integrity and documentation practices.

## Related Documents

- [483 - 2024-12-13](https://www.keypedia.com/records/483/pfizer-inc/0a8f268c-7a50-424d-b28d-4f771fa8db04) — date: December 13, 2024
- [EIR - 2021-01-08](https://www.keypedia.com/records/eir/pfizer-inc/629953a9-16fe-44af-88db-4dd1a6fe19f3) — date: January 8, 2021
- [EIR - 2018-11-02](https://www.keypedia.com/records/eir/pfizer-inc/142c3e7c-0df4-4b61-947a-8f0a135b254d) — date: November 2, 2018
- [EIR - 2018-07-18](https://www.keypedia.com/records/eir/pfizer-inc/c8390d3e-4400-4c07-aac0-d6309eb4b2d5) — date: July 18, 2018
- [EIR - 2018-06-21](https://www.keypedia.com/records/eir/pfizer-inc/b154586d-d538-42b1-a8ae-1deb0881329c) — date: June 21, 2018

## Related Officers

- [issuing_officer](https://www.keypedia.com/people/kent-a-conforti/8d3d3e82-cd97-420e-8840-df92d6eeba09)

Company: https://www.keypedia.com/companies/pfizer-inc/f8b3c75f-1ec4-46eb-97f9-f66bedfe6fe7

Office: https://www.keypedia.com/offices/division-of-northeast-imports/b20599cf-9797-41fd-947f-6589ef596a94
